CHMP rec­om­mends Ab­b­Vie's mi­graine drug, GSK's ane­mia treat­ment

The EMA’s Com­mit­tee for Med­i­c­i­nal Prod­ucts for Hu­man Use (CHMP) rec­om­mend­ed this week that the Eu­ro­pean Com­mis­sion au­tho­rize two new treat­ments for mi­graine and chron­ic …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER